Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B cell metastases

Lignende værker

• A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
  af: Tsai, Alexander K., et al.
  Udgivet: (2010)
• A novel “reduced immunogenicity” bispecific targeted toxin simultaneously recognizing human EGF and IL-4 receptors in a mouse model of metastatic breast carcinoma
  af: Oh, Seunguk, et al.
  Udgivet: (2009)
• A deimmunized bispecific ligand directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model
  af: Oh, Seunguk, et al.
  Udgivet: (2012)
• Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development
  af: Joerg U. Schmohl, et al.
  Udgivet: (2015-10-01)
• Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development
  af: Schmohl, Joerg U., et al.
  Udgivet: (2015)